<DOC>
	<DOCNO>NCT00157183</DOCNO>
	<brief_summary>The purpose study determine whether correction low nighttime oxygen ( O2 ) level and/ high carbon dioxide level patient cystic fibrosis improve quality life . The treatment use overnight ( 1 ) O2 ( 2 ) pressurise air assist breathe ( non-invasive positive pressure ventilation , NIPPV )</brief_summary>
	<brief_title>Non-invasive Ventilation Oxygen Therapy Cystic Fibrosis Patients With Nocturnal Oxygen Desaturation</brief_title>
	<detailed_description>Cystic fibrosis common life-limiting genetic disorder Caucasian population median survival 31 year . Lung disease responsible majority morbidity mortality correlate decline quality life . Respiratory failure primary cause death . Daytime respiratory failure ( hypoxia pO2 &lt; 55 and/or hypercapnia pCO2 &gt; 50 ) associate bad prognosis 2-year survival 50 % . Nocturnal respiratory failure ( great 5 % night spend SpO2 &lt; 90 % and/or rise PtcCO2 &gt; 10mmHg overnight ) precursor development daytime respiratory failure . It postulate earlier treatment respiratory failure may improve outcome quality life . Intervention : Nocturnal O2 bilevel NIPPV CF patient nocturnal respiratory failure , compare nocturnal placebo ( air ) . Crossover trial utilise patient control . Aims : ( 1 ) To assess effect non-invasive ventilation ( NIV ) oxygen ( O2 ) therapy quality life , hospital admission rate , sleep quality exercise tolerance CF patient NRF ( 2 ) To identify level severity NRF treatment NIV effective</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>proven diagnosis cystic fibrosis , age 18 year old , FEV1 &lt; 70 % predict normal , clinically stable ( admission antibiotic last 2 week , OR end admission clinical improvement expect ) , nocturnal respiratory failure ( SpO2 &lt; 90 % &gt; 10 % night rise PtcCO2 &gt; 5 mmHg REM ) , daytime hypercapnia ( PaCO2 &gt; 45 mmHg ) Previous home O2 NIV use , Sedative medication , Cardiac/renal/endocrine/neurological disease likely compromise ventilatory control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>cystic fibrosis</keyword>
	<keyword>hypoxia</keyword>
	<keyword>oxygen</keyword>
	<keyword>noninvasive ventilation</keyword>
	<keyword>quality life</keyword>
</DOC>